Dingdang Health Technology Group (HKSE:09886) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:09886 Dingdang Health Technology Group Ltd HKSE:09886
68 GF Score
Price HK$0.81
GF Value HK$1.44
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Dingdang Health Technology Group FFO?

FFO (Funds from operations) only applies to REITs.

HKSE:09886
68GF Score
Dingdang Health Technology Group Ltd HKSE:09886
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Dingdang Health Technology Group (HKSE:09886) Overvalued in 2026?

Based on GuruFocus' analysis, Dingdang Health Technology Group stock appears to be undervalued. The current stock price of HK$0.81 is trading 43.8% below its estimated GF Value™ of HK$1.44. GuruFocus considers Dingdang Health Technology Group to be Possible Value Trap.

Key valuation signals for HKSE:09886:

  • FFO:
  • GF Value™: HK$1.44 vs. price of HK$0.81 (43.8% below fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the HKSE:09886 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Dingdang Health Technology Group Business Description

Address Dengshikou Street, Building 1, Yard 50, Dongcheng District, Beijing, CHN
Dingdang Health Technology Group Ltd is an investment holding company and its subsidiaries are principally engaged in the provision of pharmaceutical and healthcare business in the PRC. It is transforming and reshaping China's healthcare industry by pioneering on-demand pharmaceutical retail and medical consultation, with online-to-offline solutions. All of the company's revenue is generated from the PRC.
68GF Score

Get the complete analysis for HKSE:09886

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.81
Price
HK$1.44
GF Value